Medico Remedies Q1 FY27: revenue up 81%, PAT up 66% YoY

Revenue growth above 20%Profit growth above 25%Results View source PDF Explain this filing

MEDICO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.1%Reaction day

₹46.70

prior close

₹47.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-4.1% vs market

Pharmaceuticals peers, median of 166sector-0.4%-3.7% vs sector

On the reaction day the stock moved 4.1 pts less than Nifty Microcap 250 and 3.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.6

10m

-5.5

15m

-3.0

30m

-3.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.1+0.1-4.1-0.4-3.7

Next day

-4.7+0.2-4.9-0.3-4.4

-8.7+0.6-9.3-0.5-8.2

-7.9-0.0-7.9-1.3-6.6

-10.6+0.5-11.1-0.8-9.8

-9.5+0.8-10.3-0.4-9.2

-9.7+0.6-10.3-0.9-8.9

15d

-14.0+1.3-15.2+0.0-14.0

-23.5-1.4-22.1-0.1-23.4

-52.7-0.6-52.1-2.6-50.0

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 166Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Medico Remedies Q1 FY27 (ended 30 June 2026): revenue from operations rose to Rs 6,940 lakhs from Rs 3,825 lakhs YoY, up about 81%. Total income Rs 7,057 lakhs. PAT grew to Rs 252 lakhs from Rs 152 lakhs, up about 66% YoY. EPS at Rs 0.30 vs Rs 0.22. Exports made up Rs 4,270 lakhs of Rs 6,903 lakhs product sales. Board re-appointed two Whole-Time Directors for 3 years and hiked MD remuneration. Auditor issued an unmodified review report.

Likely market impact

Strong Q1 with sharp revenue and PAT growth led by exports. Director re-appointments and MD pay hike signal management continuity.